387 related articles for article (PubMed ID: 22444159)
1. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
[TBL] [Abstract][Full Text] [Related]
2. Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragment.
Shao Z; Morser J; Leung LLK
J Biol Chem; 2014 Sep; 289(39):27146-27158. PubMed ID: 25112870
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
5. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
Zhao L; Leung LL; Morser J
Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.
Jin Y; Tong DY; Chen JN; Feng ZY; Yang JY; Shao CK; Li JP
PLoS One; 2012; 7(10):e48575. PubMed ID: 23119061
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
Christensen B; Sørensen ES
J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
Sun BS; Li Y; Zhang ZF; You J; Wang CL
Ann Thorac Surg; 2013 Dec; 96(6):1943-51. PubMed ID: 24094519
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
Christensen B; Schack L; Kläning E; Sørensen ES
J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.
Maeda N; Ohashi T; Chagan-Yasutan H; Hattori T; Takahashi Y; Harigae H; Hasegawa H; Yamada Y; Fujii M; Maenaka K; Uede T
Retrovirology; 2015 Nov; 12():99. PubMed ID: 26597716
[TBL] [Abstract][Full Text] [Related]
12. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo.
Dai J; Li B; Shi J; Peng L; Zhang D; Qian W; Hou S; Zhao L; Gao J; Cao Z; Zhao J; Wang H; Guo Y
Cancer Immunol Immunother; 2010 Mar; 59(3):355-66. PubMed ID: 19690854
[TBL] [Abstract][Full Text] [Related]
13. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site.
Nishimichi N; Higashikawa F; Kinoh HH; Tateishi Y; Matsuda H; Yokosaki Y
J Biol Chem; 2009 May; 284(22):14769-76. PubMed ID: 19346516
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin shapes immunosuppression in the metastatic niche.
Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
[TBL] [Abstract][Full Text] [Related]
16. OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells
Hao C; Cui Y; Hu MU; Zhi X; Zhang L; Li W; Wu W; Cheng S; Jiang WG
Anticancer Res; 2017 May; 37(5):2245-2254. PubMed ID: 28476789
[TBL] [Abstract][Full Text] [Related]
17. Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.
Goparaju CM; Pass HI; Blasberg JD; Hirsch N; Donington JS
J Thorac Oncol; 2010 Oct; 5(10):1516-23. PubMed ID: 20689445
[TBL] [Abstract][Full Text] [Related]
18. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
19. Regulatory roles of osteopontin in human lung cancer cell epithelial-to-mesenchymal transitions and responses.
Shi L; Hou J; Wang L; Fu H; Zhang Y; Song Y; Wang X
Clin Transl Med; 2021 Jul; 11(7):e486. PubMed ID: 34323425
[TBL] [Abstract][Full Text] [Related]
20. A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis.
Kon S; Nakayama Y; Matsumoto N; Ito K; Kanayama M; Kimura C; Kouro H; Ashitomi D; Matsuda T; Uede T
PLoS One; 2014; 9(12):e116210. PubMed ID: 25545242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
